Cystoid Macular Edema after Rhegmatogenous Retinal Detachment Repair with Pars Plana Vitrectomy: Rate, Risk Factors, and Outcomes.
cystoid macular edema
pars plana vitrectomy
rhegmatogenous retinal detachment
spectral-domain optical coherence tomography
vitreoretinal surgery
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
21 Aug 2022
21 Aug 2022
Historique:
received:
01
07
2022
revised:
18
08
2022
accepted:
19
08
2022
entrez:
26
8
2022
pubmed:
27
8
2022
medline:
27
8
2022
Statut:
epublish
Résumé
(1) Background: The aim was to describe the rate and outcomes of cystoid macular edema (CME) after pars plana vitrectomy (PPV) for primary rhegmatogenous retinal detachment (RRD) and to identify risk factors and imaging characteristics. (2) Methods: A retrospective consecutive case study was conducted over a 5-year period among adult patients who underwent PPV for primary RRD repair. The main outcome measure was the rate of CME at 12 months following PPV. (3) Results: Overall, 493 eyes were included. The CME rate was 28% (93 patients) at 12 months. In multivariate analysis, eyes with worse presenting visual acuity (VA) (odds ratio [OR], 1.55; 95% CI, 1.07-2.25;
Identifiants
pubmed: 36013153
pii: jcm11164914
doi: 10.3390/jcm11164914
pmc: PMC9410086
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Ophthalmic Res. 2004 Sep-Oct;36(5):241-9
pubmed: 15583429
Am J Ophthalmol. 2005 Aug;140(2):200-6
pubmed: 15992752
Eye (Lond). 2002 Jul;16(4):440-6
pubmed: 12101451
Am J Ophthalmol. 2014 Jan;157(1):214-220.e1
pubmed: 24099274
Mediators Inflamm. 2013;2013:971758
pubmed: 24288446
Ophthalmology. 2020 Nov;127(11):1507-1514
pubmed: 32437865
Ophthalmology. 2005 Aug;112(8):1421-9
pubmed: 15961159
Ophthalmology. 1980 Nov;87(11):1090-5
pubmed: 7243204
Clin Exp Ophthalmol. 2019 Apr;47(3):346-356
pubmed: 30953417
Ocul Immunol Inflamm. 2021 Jan 2;29(1):187-192
pubmed: 31577459
Acta Ophthalmol. 2021 Nov;99(7):e1190-e1197
pubmed: 33576133
Int J Retina Vitreous. 2021 Jan 25;7(1):9
pubmed: 33494835
Retina. 2021 Feb 1;41(2):309-316
pubmed: 32404843
Curr Eye Res. 2014 Feb;39(2):204-11
pubmed: 24144398
Am J Ophthalmol. 2010 Apr;149(4):630-634.e1
pubmed: 20138604
Ophthalmology. 1999 Jan;106(1):154-9
pubmed: 9917797
Korean J Ophthalmol. 2018 Jun;32(3):204-210
pubmed: 29022299
Retina. 2012 Jan;32(1):43-53
pubmed: 21778929
Prog Retin Eye Res. 2018 Mar;63:20-68
pubmed: 29126927
BMJ Open Ophthalmol. 2021 Feb 25;6(1):e000651
pubmed: 33718613
Eur J Ophthalmol. 2015 Nov-Dec;25(6):565-70
pubmed: 25907288
BMJ Clin Evid. 2008 Feb 15;2008:
pubmed: 19450333
Am J Ophthalmol. 2021 Sep;229:71-81
pubmed: 33895151
Am J Ophthalmol. 2012 Jan;153(1):128-36
pubmed: 21937016
Ophthalmology. 1998 Mar;105(3):397-405
pubmed: 9499767
Dev Ophthalmol. 2017;58:178-190
pubmed: 28351047
Retina. 2008 Jul-Aug;28(7):931-6
pubmed: 18698293
J Clin Epidemiol. 2008 Apr;61(4):344-9
pubmed: 18313558
Dev Ophthalmol. 2010;47:10-26
pubmed: 20703041
Retina. 2020 Sep;40(9):1742-1750
pubmed: 31815880
Am J Ophthalmol. 1989 Jul 15;108(1):22-9
pubmed: 2750831
Graefes Arch Clin Exp Ophthalmol. 2019 Dec;257(12):2591-2600
pubmed: 31478083
Surv Ophthalmol. 2004 Sep-Oct;49(5):470-90
pubmed: 15325193
Photonics. 2018 Jun;5(2):
pubmed: 31321222
Clin Ophthalmol. 2018 Oct 12;12:2005-2013
pubmed: 30349184